MYO MYOMO, INC.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1369290 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.3%
TTM net income YoY-25.4%
TTM EPS YoY-25.0%
Revenue 3-yr CAGR34.9%
Net income 3-yr CAGR—
Margins
Gross margin70.1%
Operating margin-21.8%
Net margin-33.1%
FCF margin-12.7%
EBITDA margin-18.8%
Returns
ROE-173.5%
ROA-44.4%
ROIC (approx.)-154.0%
Asset turnover1.34x
Leverage & solvency
Liabilities / assets91.9%
Debt / equity4.89x
Current ratio1.92x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.44x
Accruals ratio-25.0%
Payout ratio—
Capex / revenue-1.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $40.93M | $32.55M | $19.24M | $15.56M | $13.86M |
| Cost of revenue | $14.04M | $9.37M | $6.06M | $5.30M | $3.54M |
| Gross profit | $26.89M | $23.19M | $13.18M | $10.25M | $10.31M |
| R&D expense | $6.94M | $4.77M | $2.64M | $2.48M | $2.56M |
| SG&A expense | $13.96M | $12.38M | $9.73M | $18.44M | $18.02M |
| Operating income | -$14.40M | -$6.21M | -$8.23M | -$10.67M | -$10.27M |
| Pretax income | -$15.07M | -$5.82M | -$7.99M | -$10.65M | -$10.28M |
| Income tax | $504,532 | $365,617 | $156,002 | $69,937 | $88,928 |
| Net income | -$15.57M | -$6.18M | -$8.15M | -$10.72M | -$10.37M |
| EBITDA | -$13.54M | -$6.00M | -$8.07M | -$10.48M | -$10.12M |
| EPS (basic) | -0.37 | -0.16 | -0.28 | -1.52 | -1.89 |
| EPS (diluted) | -0.37 | -0.16 | -0.28 | -1.52 | -1.89 |
| Weighted avg. shares (diluted) | 41.86M | 37.76M | 29.50M | 7.05M | 5.83M |
| Balance sheet | |||||
| Cash & equivalents | $14.13M | $24.37M | $6.87M | $5.35M | $15.52M |
| Short-term investments | $4.26M | $492,990 | $1.99M | $0 | — |
| Receivables | $4.10M | $3.83M | $2.38M | $1.90M | $1.96M |
| Inventory | $3.12M | $3.17M | $1.80M | $1.40M | $808,308 |
| Current assets | $27.56M | $32.79M | $13.65M | $9.22M | $19.09M |
| PP&E, net | $2.21M | $1.33M | $175,794 | $194,283 | $275,289 |
| Total assets | $38.64M | $42.24M | $14.58M | $10.16M | $20.10M |
| Current liabilities | $8.35M | $10.17M | $5.48M | $3.60M | $4.28M |
| Short-term debt | $0 | $2.95M | — | — | — |
| Long-term debt | $11.22M | $11.22M | — | — | — |
| Total debt | $11.22M | $14.18M | — | — | — |
| Total liabilities | $27.23M | $17.53M | $5.59M | $3.80M | $4.69M |
| Shareholders' equity | $11.40M | $24.71M | $8.99M | $6.36M | $15.41M |
| Net debt | -$2.91M | -$10.20M | — | — | — |
| Shares outstanding | 38.47M | 34.38M | 27.14M | 7.75M | 6.87M |
| Cash flow statement | |||||
| Operating cash flow | -$14.51M | -$3.29M | -$6.17M | -$10.23M | -$9.55M |
| Capital expenditure | $1.74M | $1.36M | $145,816 | $111,793 | $326,462 |
| Free cash flow | -$16.25M | -$4.65M | -$6.32M | -$10.35M | -$9.87M |
| Investing cash flow | -$7.06M | $259,981 | -$2.03M | -$310,793 | -$326,462 |
| Financing cash flow | $11.43M | $20.93M | $9.71M | $376,858 | $13.17M |
| Depreciation & amortization | $859,354 | $205,910 | $164,306 | $192,799 | $145,995 |
| Stock-based compensation | $2.08M | $874,438 | $1.12M | $1.19M | $1.10M |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.